Karolinska Institutet

Karolinska Institutet is one of the world’s leading medical universities. The university’s vision is to advance knowledge about life and strive towards better health for all. Karolinska Institutet accounts for the single largest share of all academic medical research conducted in Sweden and offers the country’s broadest range of education in medicine and health sciences. The Nobel Assembly at Karolinska Institutet selects the Nobel laureates in Physiology or Medicine.

The Department of Oncology-Pathology conducts basic, translational, clinical research and teaching activities related to cancer. We aim to discover fundamental mechanisms in all aspects of cancer biology, find novel biomarkers and potent anti-cancer drugs for personalized cancer medicine. We maintain state-of art equipment for our scientists to share for a more sustainable and efficient work.

Role of institution in the project

Karolinska Institutet is mainly involved in WP 7, sharing expertise in developing a validation platform for AI models and contributing with a use case including images and clinical data.

Fredrik Strand

Fredrik Strand is a Swedish breast radiologist and associate professor at Karolinska Institutet, Stockholm. He holds an MD, PhD and MSc degrees, and has prior experience as a strategy consultant and leading a start-up company. Fredrik is head of the research and education committee at the Swedish society of breast imaging. His academic research evolves around exploring AI for breast imaging. He and his team are involved in retrospective validation of AI algorithms, prospective clinical trials, and in developing new machine-learning algorithms for breast cancer detection and supplemental MRI imaging.

Survey Invitation

Join Leading Experts In Shaping AI In Cancer

EUCAIM is looking for your feedback! We have recently published a Stakeholder Survey in order to reach out to potential end-users and stakeholders. We believe that your insights could significantly contribute to understanding the expectations of potential users and identifying the essential aspects that stakeholders find crucial for future engagement and collaboration with the platform.

Therefore, we would like to invite you to participate in the Stakeholder Survey about the Cancer Image Europe platform.

Completing the survey will take approximately 10 minutes. Your participation is crucial to the success of this project, and we deeply appreciate your expertise in shaping the future of cancer imaging and treatment.